Date: Monday, July 17th, 2023
Time: 8:45 a.m. – 4:15 p.m. CET
Poster:
P2-374 Colocalization of tau PET uptake and cerebral blood flow alterations within subjects with MCI and AD
Vice President, Medical and Scientific Affairs, Neuroscience Clario
David Scott’s aim is to facilitate drug development through standardized measurement of the neural correlates of neurodegenerative and other centrally mediated diseases. David’s focus at Clario has been to enable MRI and molecular imaging solutions toward safety, eligibility, and therapeutic efficacy endpoints. He works with radiologists, physicists, software engineers, and operational specialists on the design, execution, analysis, and interpretation of neuroscience clinical trial imaging data. His motivation is to enable neuroimaging to accelerate the delivery of therapeutic benefit to patients around the world.
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.